Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Bolt Biotherapeutics Strategic Update Conference Call. At this time, all participants are in a listen only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
2. | Water Island Capital John Orrico | 0 | $0 | 0% | |
3. | Springbok Capital Gavin Saitowitz And Cisco J. Del Valle | 0 | $0 | 0% | |
4. | GAMCO Investors Mario Gabelli | 0 | $0 | 0% | |
5. | Glazer Capital Paul Glazer | 0 | $0 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$16.22 | 5,000 | Officer, Director | 208,747 | 2014-05-09 | Filing | |
$20.00 | 5,000 | Director | 0 | 2013-11-26 | Filing | |
$14.12 | 25,235 | Officer, Director | 69,739 | 2012-11-21 | Filing | |
$11.40 | 92 | Officer | 1,142 | 2011-12-20 | Filing | |
$11.73 | 10,000 | Director | 13,800 | 2011-11-30 | Filing |